Rheumatoid arthritis

Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (Rheumatoid Arthritis and Muscle (RAMUS)): a single-arm, experimental medicine study

Lancet RheumatolPublished Prospective single-arm experimental medicine study

An erratum to this article was published (Lancet Rheumatol, May 2026 ↗)

Authors' conclusion

Tofacitinib treatment in patients with rheumatoid arthritis was associated with increased muscle volume after 6 months.

Study context

Population
Patients aged >18 years with RA (2010 ACR-EULAR criteria) initiating tofacitinib, with ≥1 sarcopenia risk factor, no previous JAKi, no systemic GC for ≥4 weeks; Freeman Hospital, Newcastle upon Tyne, UK22 screened
Participants
15 patients
Outcome
Change in lower limb muscle volume by quantitative MRI
Follow-up
1 and 6 months
Methodological detailssingle-centre, proof of concept, People with lived experience with RA were involved in the design and set-up phases
  • Single-centre
  • Proof of concept
  • People with lived experience with RA were involved in the design and set-up phases

Main finding

As reported in the abstract

Lower limb muscle volume, mean increase · 6 months

Mean increase in lower limb muscle volume, particularly in the thigh

242 cm³

95% CI 44–441p=0.017

Observational data: associations, not effects.

Secondary outcomes

Serum creatinine · 6 months

Significant increase in serum creatinine
P = 0.0011

Disease activity (DAS28-CRP) · 1 month

Significantly reduced after 1 month, no further changes at 6 months
P = 0.0064

Appendicular lean mass index, muscle strength, muscle function

No significant changes observed

Safety

OutcomeValues
Adverse eventsTofacitinib 87%
Adverse events — Total adverse events recorded
28
Adverse events — Severe and serious event (hospitalisation with COVID-19 pneumonitis before commencing tofacitinib)
1

Original publication

Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single-arm, experimental medicine study. Lancet Rheumatol. Published 15 October 2025. doi:10.1016/s2665-9913(25)00184-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.